{
    "PubTator3": [
        {
            "_id": "30757919|None",
            "id": "30757919",
            "infons": {},
            "passages": [
                {
                    "infons": {
                        "journal": "Eur J Ophthalmol. 2019 May;29(3):338-347. doi: 10.1177/1120672119827773. Epub ",
                        "year": "2019",
                        "type": "title",
                        "authors": "Belin PJ, Lee AC, Greaves G, Kosoy J, Lieberman RM"
                    },
                    "offset": 0,
                    "text": "The use of bevacizumab in pediatric retinal and choroidal disease: A review.",
                    "sentences": [],
                    "annotations": [
                        {
                            "id": "2",
                            "infons": {
                                "identifier": "MESH:D000068258",
                                "type": "Chemical",
                                "valid": true,
                                "normalized": [
                                    "D000068258"
                                ],
                                "database": "ncbi_mesh",
                                "normalized_id": "D000068258",
                                "biotype": "chemical",
                                "name": "Bevacizumab",
                                "accession": "@CHEMICAL_Bevacizumab"
                            },
                            "text": "bevacizumab",
                            "locations": [
                                {
                                    "offset": 11,
                                    "length": 11
                                }
                            ]
                        },
                        {
                            "id": "3",
                            "infons": {
                                "identifier": "MESH:D012164",
                                "type": "Disease",
                                "valid": true,
                                "normalized": [
                                    "D012164"
                                ],
                                "database": "ncbi_mesh",
                                "normalized_id": "D012164",
                                "biotype": "disease",
                                "name": "Retinal Diseases",
                                "accession": "@DISEASE_Retinal_Diseases"
                            },
                            "text": "retinal and choroidal disease",
                            "locations": [
                                {
                                    "offset": 36,
                                    "length": 29
                                }
                            ]
                        }
                    ],
                    "relations": []
                },
                {
                    "infons": {
                        "type": "abstract"
                    },
                    "offset": 77,
                    "text": "The use of intravitreal bevacizumab in pediatric retinal and uveitic disease has become more widespread over the past decade. This article serves to outline the rationale underlying the use of intravitreal bevacizumab, and which disease entities it should be appropriately thought of as a primary or solo therapy, as opposed to an adjuvant one. Also presented is the relevant literature regarding each of these retinopathies.",
                    "sentences": [],
                    "annotations": [
                        {
                            "id": "8",
                            "infons": {
                                "identifier": "MESH:D000068258",
                                "type": "Chemical",
                                "valid": true,
                                "normalized": [
                                    "D000068258"
                                ],
                                "database": "ncbi_mesh",
                                "normalized_id": "D000068258",
                                "biotype": "chemical",
                                "name": "Bevacizumab",
                                "accession": "@CHEMICAL_Bevacizumab"
                            },
                            "text": "bevacizumab",
                            "locations": [
                                {
                                    "offset": 101,
                                    "length": 11
                                }
                            ]
                        },
                        {
                            "id": "9",
                            "infons": {
                                "identifier": "MESH:D012164",
                                "type": "Disease",
                                "valid": true,
                                "normalized": [
                                    "D012164"
                                ],
                                "database": "ncbi_mesh",
                                "normalized_id": "D012164",
                                "biotype": "disease",
                                "name": "Retinal Diseases",
                                "accession": "@DISEASE_Retinal_Diseases"
                            },
                            "text": "retinal and uveitic disease",
                            "locations": [
                                {
                                    "offset": 126,
                                    "length": 27
                                }
                            ]
                        },
                        {
                            "id": "10",
                            "infons": {
                                "identifier": "MESH:D000068258",
                                "type": "Chemical",
                                "valid": true,
                                "normalized": [
                                    "D000068258"
                                ],
                                "database": "ncbi_mesh",
                                "normalized_id": "D000068258",
                                "biotype": "chemical",
                                "name": "Bevacizumab",
                                "accession": "@CHEMICAL_Bevacizumab"
                            },
                            "text": "bevacizumab",
                            "locations": [
                                {
                                    "offset": 283,
                                    "length": 11
                                }
                            ]
                        },
                        {
                            "id": "11",
                            "infons": {
                                "identifier": "MESH:D058437",
                                "type": "Disease",
                                "valid": true,
                                "normalized": [
                                    "D058437"
                                ],
                                "database": "ncbi_mesh",
                                "normalized_id": "D058437",
                                "biotype": "disease",
                                "name": "Hypertensive Retinopathy",
                                "accession": "@DISEASE_Hypertensive_Retinopathy"
                            },
                            "text": "retinopathies",
                            "locations": [
                                {
                                    "offset": 488,
                                    "length": 13
                                }
                            ]
                        }
                    ],
                    "relations": []
                }
            ],
            "relations": [
                {
                    "id": "R1",
                    "infons": {
                        "score": "0.9988",
                        "role1": {
                            "identifier": "MESH:D000068258",
                            "type": "Chemical",
                            "valid": true,
                            "normalized": [
                                "D000068258"
                            ],
                            "database": "ncbi_mesh",
                            "normalized_id": "D000068258",
                            "biotype": "chemical",
                            "name": "Bevacizumab",
                            "accession": "@CHEMICAL_Bevacizumab"
                        },
                        "role2": {
                            "identifier": "MESH:D012164",
                            "type": "Disease",
                            "valid": true,
                            "normalized": [
                                "D012164"
                            ],
                            "database": "ncbi_mesh",
                            "normalized_id": "D012164",
                            "biotype": "disease",
                            "name": "Retinal Diseases",
                            "accession": "@DISEASE_Retinal_Diseases"
                        },
                        "type": "Negative_Correlation"
                    },
                    "nodes": [
                        {
                            "refid": "0",
                            "role": "0,1"
                        }
                    ]
                }
            ],
            "pmid": 30757919,
            "pmcid": null,
            "meta": {},
            "date": "2019-05-01T00:00:00Z",
            "journal": "Eur J Ophthalmol",
            "authors": [
                "Belin PJ",
                "Lee AC",
                "Greaves G",
                "Kosoy J",
                "Lieberman RM"
            ],
            "relations_display": [
                {
                    "name": "treat|@CHEMICAL_Bevacizumab|@DISEASE_Retinal_Diseases"
                }
            ]
        }
    ]
}